| Literature DB >> 25338101 |
Huaishun Shen1, Yacheng Hu1, Yuanchao Ma1, Xin Zhou2, Zenghong Xu2, Yan Shui2, Chunyan Li3, Peng Xu3, Xiaowen Sun3.
Abstract
The red swamp crayfish Procambarus clarkii is a highly adaptable, tolerant, and fecund freshwater crayfish that inhabits a wide range of aquatic environments. It is an important crustacean model organism that is used in many research fields, including animal behavior, environmental stress and toxicity, and studies of viral infection. Despite its widespread use, knowledge of the crayfish genome is very limited and insufficient for meaningful research. This is the use of next-generation sequencing techniques to analyze the crayfish transcriptome. A total of 324.97 million raw reads of 100 base pairs were generated, and a total of 88,463 transcripts were assembled de novo using Trinity software, producing 55,278 non-redundant transcripts. Comparison of digital gene expression between four different tissues revealed differentially expressed genes, in which more overexpressed genes were found in the hepatopancreas than in other tissues, and more underexpressed genes were found in the testis and the ovary than in other tissues. Gene ontology (GO) and KEGG enrichment analysis of differentially expressed genes revealed that metabolite- and immune-related pathway genes were enriched in the hepatopancreas, and DNA replication-related pathway genes were enriched in the ovary and the testis, which is consistent with the important role of the hepatopancreas in metabolism, immunity, and the stress response, and with that of the ovary and the testis in reproduction. It was also found that 14 vitellogenin transcripts were highly expressed specifically in the hepatopancreas, and 6 transcripts were highly expressed specifically in the ovary, but no vitellogenin transcripts were highly expressed in both the hepatopancreas and the ovary. These results provide new insight into the role of vitellogenin in crustaceans. In addition, 243,764 SNP sites and 43,205 microsatellite sequences were identified in the sequencing data. We believe that our results provide an important genome resource for the crayfish.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25338101 PMCID: PMC4206422 DOI: 10.1371/journal.pone.0110548
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of Illumina Hiseq2000 assembly and analysis of P. clarkii transcriptomic sequences.
| Type | Number |
| Total genes | 50219 |
| Total transcripts | 88463 |
| Total residues | 146449732 |
| Average length | 1655.49 |
| Largest transcript | 34708 |
| Smallest transcript | 351 |
Figure 1Length distribution of assembled transcripts of P. clarkii.
Figure 2Gene ontology (GO) classification of transcripts of P. clarkii.
GO terms were processed by Blast2Go and categorized at level 2 under three main categories (biological process, cellular component, and molecular function).
Figure 3Cluster of orthologous groups (COG) classification of putative proteins.
Figure 4KEGG Classification of the genes.
14596 transcripts were assigned to 311 KEGG pathways. The top 20 most abundant KEGG pathways are shown.
Figure 5Differentially expressed genes analysis of four different crayfish tissues.
hep: hepatopancreas; mu: muscle; ov: ovary; te: testis.
KEGG pathways enriched in 4 crayfish tissues with Bonferroni-corrected p-values.
| tissue 1 | tissue 2 | #Term | Sample number | Background number | Corrected P-Value |
| hepato-pancreas | muscle | Lysosome | 148 | 272 | 7.27E-07 |
| Galactose metabolism | 45 | 66 | 1.96E-05 | ||
| Peroxisome | 79 | 138 | 5.42E-05 | ||
| Regulation of actin cytoskeleton | 169 | 342 | 5.45E-05 | ||
| Rheumatoid arthritis | 39 | 58 | 0.000139 | ||
| Methane metabolism | 34 | 49 | 0.000183 | ||
| PPAR signaling pathway | 49 | 79 | 0.000186 | ||
| Bacterial invasion of epithelial cells | 90 | 169 | 0.000266 | ||
| Starch and sucrose metabolism | 64 | 112 | 0.000267 | ||
| Focal adhesion | 184 | 389 | 0.000278 | ||
| Arachidonic acid metabolism | 61 | 107 | 0.000422 | ||
| Basal cell carcinoma | 38 | 60 | 0.000693 | ||
| Sphingolipid metabolism | 56 | 98 | 0.000766 | ||
| Glutathione metabolism | 58 | 103 | 0.000904 | ||
| Glycolysis/Gluconeogenesis | 56 | 100 | 0.001221 | ||
| Other glycan degradation | 42 | 71 | 0.001747 | ||
| Retinol metabolism | 22 | 31 | 0.001909 | ||
| Metabolism of xenobiotics by cytochrome P450 | 37 | 61 | 0.00197 | ||
| Alanine, aspartate and glutamate metabolism | 32 | 51 | 0.002217 | ||
| Pentose phosphate pathway | 35 | 58 | 0.003069 | ||
| Type II diabetes mellitus | 30 | 48 | 0.003427 | ||
| Shigellosis | 66 | 128 | 0.005031 | ||
| Phagosome | 100 | 208 | 0.005674 | ||
| Fatty acid metabolism | 34 | 58 | 0.006587 | ||
| Viral myocarditis | 81 | 165 | 0.007891 | ||
| Drug metabolism - other enzymes | 35 | 61 | 0.008885 | ||
| Nitrogen metabolism | 22 | 34 | 0.009292 | ||
| Endometrial cancer | 53 | 102 | 0.012052 | ||
| Pyruvate metabolism | 39 | 71 | 0.013601 | ||
| Pentose and glucuronate interconversions | 24 | 39 | 0.014534 | ||
| Amino sugar and nucleotide sugar metabolism | 61 | 124 | 0.026912 | ||
| Caffeine metabolism | 9 | 11 | 0.028532 | ||
| Antigen processing and presentation | 33 | 61 | 0.037375 | ||
| Proximal tubule bicarbonate reclamation | 21 | 35 | 0.038357 | ||
| Cytokine-cytokine receptor interaction | 16 | 25 | 0.044251 | ||
| Drug metabolism - cytochrome P450 | 30 | 55 | 0.044251 | ||
| hepato-pancreas | ovary | Ribosome | 85 | 91 | 0 |
| Lysosome | 188 | 272 | 4.53E-08 | ||
| Drug metabolism - cytochrome P450 | 49 | 55 | 2.00E-07 | ||
| Metabolism of xenobiotics by cytochrome P450 | 51 | 61 | 7.90E-06 | ||
| Oxidative phosphorylation | 96 | 135 | 5.70E-05 | ||
| Glutathione metabolism | 76 | 103 | 6.91E-05 | ||
| Rheumatoid arthritis | 44 | 58 | 0.004021 | ||
| Sphingolipid metabolism | 68 | 98 | 0.004644 | ||
| Retinol metabolism | 26 | 31 | 0.004991 | ||
| Lysine degradation | 92 | 140 | 0.006405 | ||
| Pentose and glucuronate interconversions | 31 | 39 | 0.006589 | ||
| Fatty acid metabolism | 42 | 58 | 0.017066 | ||
| Ascorbate and aldarate metabolism | 18 | 21 | 0.023131 | ||
| Cell cycle | 116 | 188 | 0.023826 | ||
| Arginine and proline metabolism | 59 | 88 | 0.023826 | ||
| Arachidonic acid metabolism | 70 | 107 | 0.023826 | ||
| Parkinson's disease | 82 | 129 | 0.031582 | ||
| PPAR signaling pathway | 53 | 79 | 0.036184 | ||
| Melanoma | 41 | 59 | 0.039756 | ||
| hepato-pancreas | testis | Lysosome | 163 | 272 | 4.82E-07 |
| Peroxisome | 91 | 138 | 2.02E-06 | ||
| Amino sugar and nucleotide sugar metabolism | 83 | 124 | 2.14E-06 | ||
| Fatty acid metabolism | 44 | 58 | 1.18E-05 | ||
| Rheumatoid arthritis | 43 | 58 | 4.29E-05 | ||
| Starch and sucrose metabolism | 72 | 112 | 7.17E-05 | ||
| Oxidative phosphorylation | 84 | 135 | 7.17E-05 | ||
| Metabolism of xenobiotics by cytochrome P450 | 44 | 61 | 7.95E-05 | ||
| Drug metabolism - cytochrome P450 | 40 | 55 | 0.000155 | ||
| Glutathione metabolism | 65 | 103 | 0.0004 | ||
| Drug metabolism - other enzymes | 42 | 61 | 0.000658 | ||
| Retinol metabolism | 24 | 31 | 0.002129 | ||
| Galactose metabolism | 43 | 66 | 0.003549 | ||
| Pentose and glucuronate interconversions | 28 | 39 | 0.004508 | ||
| Valine, leucine and isoleucine degradation | 41 | 63 | 0.004508 | ||
| Sphingolipid metabolism | 59 | 98 | 0.004508 | ||
| Aminobenzoate degradation | 16 | 19 | 0.004508 | ||
| Butanoate metabolism | 30 | 43 | 0.004508 | ||
| Other glycan degradation | 45 | 71 | 0.004508 | ||
| beta-Alanine metabolism | 26 | 36 | 0.004797 | ||
| Alanine, aspartate and glutamate metabolism | 34 | 51 | 0.006232 | ||
| Arginine and proline metabolism | 53 | 88 | 0.007429 | ||
| DNA replication | 42 | 67 | 0.008497 | ||
| PPAR signaling pathway | 48 | 79 | 0.009379 | ||
| Arachidonic acid metabolism | 62 | 107 | 0.009379 | ||
| Histidine metabolism | 19 | 25 | 0.009451 | ||
| Cysteine and methionine metabolism | 36 | 56 | 0.009451 | ||
| Two-component system | 16 | 20 | 0.009557 | ||
| Nitrogen metabolism | 24 | 34 | 0.010345 | ||
| Parkinson's disease | 72 | 129 | 0.013287 | ||
| Antigen processing and presentation | 38 | 61 | 0.014212 | ||
| Tyrosine metabolism | 28 | 43 | 0.023795 | ||
| Propanoate metabolism | 29 | 45 | 0.024472 | ||
| Glycosaminoglycan degradation | 30 | 47 | 0.024998 | ||
| Pyrimidine metabolism | 89 | 168 | 0.026852 | ||
| Glycine, serine and threonine metabolism | 44 | 75 | 0.029221 | ||
| Synthesis and degradation of ketone bodies | 15 | 20 | 0.032987 | ||
| Glycolysis/Gluconeogenesis | 56 | 100 | 0.032987 | ||
| Tryptophan metabolism | 32 | 52 | 0.035613 | ||
| Meiosis - yeast | 63 | 115 | 0.035613 | ||
| Nucleotide excision repair | 43 | 74 | 0.036095 | ||
| Collecting duct acid secretion | 17 | 24 | 0.041595 | ||
| Pyruvate metabolism | 41 | 71 | 0.048078 | ||
| ovary | muscle | Ribosome | 81 | 91 | 0 |
| Protein processing in endoplasmic reticulum | 134 | 240 | 0.001548 | ||
| Type II diabetes mellitus | 35 | 48 | 0.001548 | ||
| Glycolysis/Gluconeogenesis | 63 | 100 | 0.001843 | ||
| DNA replication | 43 | 67 | 0.014867 | ||
| Colorectal cancer | 61 | 102 | 0.014867 | ||
| Insulin signaling pathway | 123 | 230 | 0.019284 | ||
| Cell cycle | 102 | 188 | 0.024154 | ||
| Focal adhesion | 196 | 389 | 0.024154 | ||
| Mismatch repair | 32 | 49 | 0.027405 | ||
| Homologous recombination | 38 | 61 | 0.02987 | ||
| Fanconi anemia pathway | 60 | 105 | 0.033469 | ||
| Basal cell carcinoma | 37 | 60 | 0.036003 | ||
| Thyroid cancer | 14 | 18 | 0.04045 | ||
| Melanoma | 36 | 59 | 0.044224 | ||
| Prostate cancer | 51 | 89 | 0.044446 | ||
| testis | muscle | RNA polymerase | 47 | 69 | 0.000652 |
| Focal adhesion | 199 | 389 | 0.002043 | ||
| Glycolysis/Gluconeogenesis | 61 | 100 | 0.002043 | ||
| Carbon fixation in photosynthetic organisms | 29 | 42 | 0.007085 | ||
| Bladder cancer | 19 | 25 | 0.011212 | ||
| Basal cell carcinoma | 38 | 60 | 0.011212 | ||
| Cytosolic DNA-sensing pathway | 30 | 45 | 0.011555 | ||
| Pyrimidine metabolism | 90 | 168 | 0.018107 | ||
| Colorectal cancer | 58 | 102 | 0.021629 | ||
| Regulation of actin cytoskeleton | 168 | 342 | 0.03891 | ||
| ovary | testis | Ribosome | 80 | 91 | 0 |
Figure 6RT-PCR amplification and agarose gel (1.5%) electrophoresis of 20 transcripts.
G01–G20: names of transcripts, represented transcript_ID given in Table S10 in File S1; 18S: 18S rRNA transcript; He: hepatopancreas; Mu: muscle; Ov: ovary; Te: testis; M: DNA marker.
Figure 7Classification of SNPs identified in the crayfish transcriptome.
Figure 8Distribution of simple sequence repeat (SSR) nucleotide classes among different nucleotide types found in the transcriptome of P. clarkii.